P1463: HEALTHCARE RESOURCE USE, ECONOMIC BURDEN AND IN-PATIENT MORTALITY IN PATIENTS WITH ALPHA- AND BETA-THALASSEMIA COMPARED TO MATCHED CONTROLS IN THE REAL-WORLD SETTING
Arielle L. Langer,
Louise Lombard,
Amey Rane,
Keely Gilroy,
Junlong LI,
Jing Zhao,
Carolyn Lew,
Erin Bullock,
Brian Davis,
Sujit Sheth
Affiliations
Arielle L. Langer
1 Brigham and Women’s Hospital, Hematology, Boston, United States
Louise Lombard
2 Agios Pharmaceuticals, Health Economics and Outcomes Research, Cambridge, United States
Amey Rane
3 Agios, Health Economics and Outcomes Research, Cambridge, United States
Keely Gilroy
4 Agios, Medical Affairs, Cambridge, United States
Junlong LI
5 Agios, Biometrics, Cambridge, United States
Jing Zhao
5 Agios, Biometrics, Cambridge, United States
Carolyn Lew
6 Merative, Cambridge, United States
Erin Bullock
6 Merative, Cambridge, United States
Brian Davis
6 Merative, Cambridge, United States
Sujit Sheth
7 Weill Cornell Medicine, Division of Pediatric Hematology/Oncology,, New York, United States
